title: The mystique of hepatic tolerogenicity.
abstract: The evolution of clinical transplantation has hinged on 2 seminal turning points. The first was the demonstration in 1953 by Billingham, Brent, and Medawar that chimerism-associated tolerance could be induced deliberately in neonatal mice by infusing adult donor hematolymphopoietic cells. This discovery escalated in a straight line over the next 15 years to successful bone marrow transplantation in humans. The second turning point was the demonstration that organ allografts could self-induce tolerance under an umbrella of immunosuppression, or in some species without immunosuppression. Unfortunately, it was incorrectly concluded by most immunologists and surgeons that bone marrow and organ engraftment involved different immune mechanisms. In a derivative error, it became widely believed that the tolerogenicity of the liver differed fundamentally not only from that of bone marrow but also from that of other whole organs. These errors became dogma and were not corrected until low level donor leukocyte chimerism was found in humans and animals bearing long surviving liver, kidney, heart, and other kinds of allografts. With successful bone marrow transplantation, the trace population consisted of recipient rather than donor leukocytes. Thus, the consequences of organ and bone marrow engraftment were mirror images. From these observations, it was proposed that the engraftment of all kinds of organs as well as bone marrow cells (BMC) involved host versus graft (HVG) and graft versus host (GVH) reactions with reciprocal induction of variable degrees of specific non-reactivity (tolerance). The maintenance of the tolerance was an active and ongoing process requiring the persistence of the transplanted fragment of the donor immune system. The immune responsiveness and unresponsiveness to both organ and bone marrow allografts are thought to be governed by the migration and localization of leukocytes. The clarifying principles of tranplantation immunology that have emerged from the chimerism studies are relevant to the adaptive immune response to microbial, tumor, allogeneic, and self antigens. These principles should be used to guide efforts to systematically induce tolerance to human tissues and organs, and perhaps ultimately to xenografts.
authors.affiliation: Transplantation Institute, Departments of Surgery, Pathology, and Pediatrics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
authors.forename: N
authors.initials: N
authors.lastname: Murase
authors.forename: A
authors.initials: A
authors.lastname: Demetris
authors.forename: M
authors.initials: M
authors.lastname: Trucco
authors.forename: J
authors.initials: J
authors.lastname: Fung
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation / Q000276:immunology; D002465:Cell Movement; D002678:Chimera; D002999:Clone Cells; D006801:Humans; D007108:Immune Tolerance; D007962:Leukocytes / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous